A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata
Authors
Keywords
-
Journal
ARCHIVES OF DERMATOLOGICAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-01
DOI
10.1007/s00403-022-02336-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An integrated scalp and blood biomarker approach suggeststhe systemic nature of alopecia areata
- (2021) Jacob W. Glickman et al. ALLERGY
- Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
- (2020) Hidemi Nakagawa et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients
- (2020) Khalaf Kridin et al. Journal of Allergy and Clinical Immunology-In Practice
- Delgocitinib: First Approval
- (2020) Sohita Dhillon DRUGS
- Cross-sectional study of blood biomarkers of patients with moderate-to-severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation
- (2020) Jacob W. Glickman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- JAK inhibitors for alopecia areata: a systematic review and meta-analysis
- (2019) Kevin Phan et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomised, double‐blind, vehicle‐controlled Phase 2a study
- (2019) M. Worm et al. BRITISH JOURNAL OF DERMATOLOGY
- Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis
- (2019) Hidemi Nakagawa et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- (2019) Farzan Solimani et al. Frontiers in Immunology
- Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study
- (2018) H. Nakagawa et al. BRITISH JOURNAL OF DERMATOLOGY
- A Case Report Highlighting the Effective Treatment of Alopecia Universalis With Tofacitinib in an Adolescent and Adult Patient
- (2018) Nupur U. Patel et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- (2018) A. Jabbari et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- (2018) Kunal Malik et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS
- Methotrexate for alopecia areata: a systematic review and meta-analysis
- (2018) Kevin Phan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- (2018) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- (2018) Elana Putterman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Alopecia areata
- (2018) Lauren C. Strazzulla et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Alopecia areata
- (2018) Lauren C. Strazzulla et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- (2018) Solam Lee et al. JAMA Dermatology
- Alopecia areata: A multifactorial autoimmune condition
- (2018) Teontor Simakou et al. JOURNAL OF AUTOIMMUNITY
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- (2017) Amy Vandiver et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Sequential high- and low-dose systemic corticosteroid therapy for severe childhood alopecia areata
- (2017) Karin Jahn-Bassler et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
- (2017) Hyun-Sun Park et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- (2017) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- (2017) Cheryl B. Bayart et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of Alopecia Areata With Tofacitinib
- (2017) Omer Ibrahim et al. JAMA Dermatology
- Alopecia areata
- (2017) C. Herbert Pratt et al. Nature Reviews Disease Primers
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- (2016) Ali Jabbari et al. EXPERIMENTAL DERMATOLOGY
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- (2016) Judilyn Fuentes-Duculan et al. EXPERIMENTAL DERMATOLOGY
- Multiple courses of pulse corticosteroid therapy for alopecia areata
- (2016) Takashi Yoshimasu et al. JOURNAL OF DERMATOLOGY
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- (2016) John E. Harris et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- (2016) A.K. Gupta et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- KEGG: new perspectives on genomes, pathways, diseases and drugs
- (2016) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- (2016) Arjun Dhayalan et al. JAMA Dermatology
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- (2016) Brittany G. Craiglow et al. JAMA Dermatology
- Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata
- (2015) Xiaoting Zhang et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation
- (2015) Eleanor Higgins et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- (2015) Mayte Suárez-Fariñas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- KEGG as a reference resource for gene and protein annotation
- (2015) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- (2015) Ali Jabbari et al. EBioMedicine
- Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia
- (2014) Lisa Pieri et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology
- (2014) Saakshi Khattri et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- (2014) Brittany G. Craiglow et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inhibiting Janus kinases to treat alopecia areata
- (2014) Sherrie J Divito et al. NATURE MEDICINE
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- (2014) Luzhou Xing et al. NATURE MEDICINE
- The effect of oral cyclosporine in the treatment of severe alopecia areata
- (2013) Gürol Açıkgöz et al. Cutaneous and Ocular Toxicology
- Current Treatment of Alopecia Areata
- (2013) Jerry Shapiro JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS
- CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase
- (2012) Taisuke Ito et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Alopecia Areata
- (2012) Amos Gilhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in the management of alopecia areata
- (2011) Taisuke ITO JOURNAL OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now